Viewing Study NCT04429503


Ignite Creation Date: 2025-12-24 @ 7:38 PM
Ignite Modification Date: 2026-04-07 @ 4:44 PM
Study NCT ID: NCT04429503
Status: COMPLETED
Last Update Posted: 2025-08-08
First Post: 2020-05-26
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease
Sponsor: Regeneron Pharmaceuticals
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetic Macular Edema View
None Type 1 Diabetes Mellitus View
None Type 2 Diabetes Mellitus View
Keywords: